CDH17 and breast carcinoma: This is consistent with prior studies reporting overexpression of cadherins in various cancers, such as breast cancer (Van Roy, 2014) and colorectal cancer (Abdelmaksoud-Dammak et al., 2017), emphasizing their involvement in tumor progression.